Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Return on Tangible Equity of -53.24% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-78.54M |
|
-- |
|
-- |
|
$85.31M |
|
$-85.31M |
|
$6.77M |
|
$-78.54M |
|
$-78.54M |
|
$-78.54M |
|
$-78.54M |
|
$-78.54M |
|
$-78.54M |
|
$-85.31M |
|
$-86.44M |
|
13.32M |
|
13.32M |
|
$-5.90 |
|
$-5.90 |
|
| Balance Sheet Financials | |
$166.95M |
|
$0.16M |
|
$1.24M |
|
$168.19M |
|
$20.69M |
|
-- |
|
-- |
|
$20.69M |
|
$147.50M |
|
$147.50M |
|
$147.50M |
|
17.61M |
|
| Cash Flow Statement Financials | |
$-64.49M |
|
$-1.64M |
|
$77.43M |
|
$17.87M |
|
$29.16M |
|
$11.29M |
|
$6.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-53.24% |
|
|
Return on Tangible Equity |
-53.24% |
-46.69% |
|
-53.24% |
|
$8.38 |
|
$-4.84 |
|
$-4.84 |
|